takeda christophe weber

Takeda, Christophe Weber

Drugmaker Takeda's CEO Weber to step down, raises profit forecast

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook. Julie Kim,

MM&M · 3d

Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed him

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S. business unit.

STAT · 3d

Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price over the last couple of years.

FiercePharma2d

Fierce Pharma Asia—Takeda's next CEO; Enhertu's novel FDA nod; East Asian American C-suite execs

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed

Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Takeda, Christophe Weber

Trending now